| Literature DB >> 28877862 |
Mirjam Pot1,2, Theo Gwm Paulussen1, Robert Ac Ruiter2, Iris Eekhout1,3, Hester E de Melker4, Maxine Ea Spoelstra5, Hilde M van Keulen1.
Abstract
BACKGROUND: In 2010, the human papillomavirus (HPV) vaccination was introduced in the Dutch National Immunization Program for 12-year-old girls, aiming to reduce the incidence of cervical cancer in women. HPV vaccination uptake turned out to be lower than expected: 61% versus 70%, respectively. Mothers were shown to play the most important role in the immunization decision about this vaccination. They had also expressed their need for interactive personal information about the HPV vaccination over and above the existing universal general information. To improve the effectiveness of the existing education about the HPV vaccination, we systematically developed a Web-based tailored intervention with virtual assistants providing mothers of girls to be invited with tailored feedback on their decision making about the HPV vaccination.Entities:
Keywords: health promotion; randomized controlled trial; vaccination; web-based intervention computer-tailoring
Mesh:
Year: 2017 PMID: 28877862 PMCID: PMC5607435 DOI: 10.2196/jmir.7449
Source DB: PubMed Journal: J Med Internet Res ISSN: 1438-8871 Impact factor: 5.428
Figure 1Timeline of data collection for the control and intervention group.
Figure 2Screenshot of the decisional balance and the mother-like virtual assistant on the website.
Overview of primary and secondary outcome measures.
| Measures and items | Score/scale | Cronbach alpha (α) or Pearson | References | ||||
|
|
|
|
| ||||
|
|
| 0=not vaccinated, 1=vaccinated | N/Ab |
| |||
|
|
| Uptake of the HPV vaccination is obtained through data from Praeventis. | |||||
|
|
|
|
| ||||
|
|
| 0=not informed, 1=informed | N/A | [ | |||
|
|
| An informed decision has been made when: | |||||
|
|
|
| The knowledge score was higher or equal to the mean of knowledge at baseline, the attitude score was higher than 4 (positive) and the HPV vaccination has been received. | ||||
|
|
|
| The knowledge score was higher or equal to the mean of knowledge at baseline, the attitude score was lower than 4 (negative), and the HPV vaccination has not been received. | ||||
|
|
|
| Any other combination was categorized as an uninformed decision. | ||||
|
|
| 0=least informed decision to 48=most informed decision | N/A | [ | |||
|
|
| Attitude was recoded from 0-7 to −3 (negative) to 3 (positive attitude) and HPV uptake was recoded from 0 or 1 to −1 (no injection) or 1 (1 or 2 injections). | |||||
|
|
| Level of consistency was measured by multiplying the scores for attitude by those for HPV uptake (−3=low consistency; 3=high consistency). Consistency was then recoded into 0 (low) to 6 (high). Both consistency and sufficient knowledge were considered prerequisite for an informed decision. | |||||
|
|
| Knowledge scores (−8=low; 8=high) lower or equal to 0 were considered insufficient (0=no insufficient knowledge; 8=high knowledge). | |||||
|
|
| The level of IDM outcome was determined by multiplying the scores for knowledge with those for consistency. | |||||
|
|
| 1=high to 7=low decisional conflict | .94 (α) | [ | |||
|
|
| As regards the HPV vaccination: | |||||
|
|
|
| I felt sure about my choice | ||||
|
|
|
| The decision was relatively easy to make | ||||
|
|
|
| I was clear about the best choice for my daughter | ||||
|
|
| 1=low intention to vaccinate to 7=high intention to vaccinate | .92 ( | [ | |||
|
|
| Are you planning on getting your daughter vaccinated against HPV? | |||||
|
|
| How big is the chance that you will get your daughter vaccinated? | |||||
|
|
| 1=negative to 7=positive attitude | .98 (α) | [ | |||
|
|
| Vaccinating my daughter against HPV is... | |||||
|
|
|
| very undesirable to very desirable | ||||
|
|
|
| very bad to very good | ||||
|
|
|
| very negative to very positive | ||||
|
|
|
| very unimportant to very important | ||||
|
|
| 1=low to 7=high risk perception | N/A | [ | |||
|
|
| Imagine that your daughter was not vaccinated against HPV. | |||||
|
|
|
| The chance that my daughter will get cervical cancer is... | ||||
|
|
| 1=low to 7=high risk perception | N/A | [ | |||
|
|
| Imagine that your daughter was vaccinated against HPV. | |||||
|
|
|
| The chance that my daughter will get cervical cancer is... | ||||
|
|
| 1=low to 7=high anticipated regret | N/A | [ | |||
|
|
| Imagine your daughter has not received the HPV vaccination and she gets cervical cancer in the future. |
|
|
| ||
|
|
|
| How much would you regret your decision to let her receive no vaccination? | ||||
|
|
| 1=negative to 7=positive beliefs about the HPV vaccination | .85 (α) | [ | |||
|
|
| If the government offers the vaccination, I assume it will be safe. | |||||
|
|
| Our government shows responsibility for the health of the Dutch population by introducing the HPV vaccination. | |||||
|
|
| The HPV vaccination was only introduced because the pharmaceutical industry will earn a lot of money from it (R). | |||||
|
|
| There is too little known about whether the HPV vaccination effectively protects against cervical cancer (R). | |||||
|
|
| There is too little known about the detrimental side effects of the HPV vaccination (R). | |||||
|
|
| My daughter is too young to receive the HPV vaccination (R). | |||||
|
|
| My daughter does not need the vaccination because she is not yet sexually active (R). | |||||
|
|
| −20=negative to 20=positive | .64 ( | [ | |||
|
|
| Normative beliefs: | |||||
|
|
|
| Regarding the HPV vaccination of your daughter, what is your expectation on the opinion of... | ||||
|
|
|
|
| Social referents: partnere, daughter | |||
|
|
| Motivation to comply: | |||||
|
|
|
| How motivated are you to comply with the opinion of...? | ||||
|
|
| 1=weak to 7=strong habit strength | .78 ( | [ | |||
|
|
| Letting my daughter receive the HPV vaccination is something I do: | |||||
|
|
|
| automatically | ||||
|
|
|
| without thinking | ||||
|
|
| 1=low self-efficacy to 7=high self-efficacy | .82 (α) |
| |||
|
|
| To what extent would you succeed in dealing with the following statements? | |||||
|
|
|
| Guiding my daughter in the decision regarding the HPV vaccination | ||||
|
|
|
| Having a good talk with my daughter about the HPV vaccination | ||||
|
|
|
| Having a good talk with my partnere about the HPV vaccination | ||||
|
|
|
| Motivating my daughter to have herself vaccinated | ||||
|
|
|
| Getting the actual HPV vaccination/2 injections with my daughter | ||||
|
|
| −8=incorrect, 8=correct | N/A | [ | |||
|
|
| Are the following statements true or false? | |||||
|
|
|
| HPV is sexually transmittable. | ||||
|
|
|
| Condoms fully protect against HPV. | ||||
|
|
|
| My daughter is obliged to get the HPV vaccination when she is invited. | ||||
|
|
|
| You will always notice when you are infected by HPV. | ||||
|
|
|
| Only women can get infected by HPV. | ||||
|
|
|
| Women who received the HPV vaccination are still advised to participate in the cervical cancer screening in the Netherlands. | ||||
|
|
|
| The HPV vaccination fully protects against cervical cancer. | ||||
|
|
|
| My daughter does not need to get the HPV vaccination if she is already sexually active. | ||||
|
|
| −9=HPV vaccination least effective to 9=HPV vaccination most effective | N/A | [ | |||
|
|
| How would you rate the effectiveness of the following methods of preventing cervical cancer: |
|
|
| ||
|
|
|
| having safe sex | ||||
|
|
|
| having sex with only 1 person in a lifetime | ||||
|
|
|
| participating in the cervical cancer screening | ||||
|
|
|
| having a healthy lifestyle (eg, not smoking) | ||||
|
|
|
| the HPV vaccination | ||||
|
|
|
| Participants rated the effectiveness of each method | ||||
aHPV: human papillomavirus.
bN/A: not applicable.
cIDM: informed decision making.
dThe subjective norms score was first computed by multiplying normative beliefs and motivation to comply for each social referent, and then by summing up the multiplications of the social referents.
eOnly applicable if the mother indicated that she had a partner.
fKnowledge is not a scale because the answer on 1 item does not predict the answer on other items; the items were summed up to present a sum score of knowledge.
gThe difference between the rated effectiveness of the HPV vaccination and the most effective alternative represented the relative effectiveness score (−9=HPV vaccination least effective to 9=HPV vaccination most effective).
Figure 3Flow diagram of the recruitment and response of study participants. Notes: (1) Participants could be excluded based on multiple criteria (eg, a male with an invalid age). Therefore, the total number of Praeventis participants excluded differed from the sum of separate criteria for exclusion. (2) In order to assess the intervention’s effectiveness (Praeventis sample) versus efficacy (panel sample), the recruitment and response is displayed per sample within each condition.
Sample description (N=8062). In case of missing values, the number of missing values (Nmissing) was presented. By reporting 2 decimal points for the percentages, summing the percentages for each category up may differ from 100%.
| Variables | Intervention (ntotal=3995), n (%) | Control (ntotal=4067), n (%) | Total (Ntotal=8062), n (%) | |
| Age in years, n (%) | 43.70 (4.27) | 43.58 (4.22) | 43.64 (4.25) | |
|
| Nmissing=4 (0.10) | Nmissing=4 (0.10) | Nmissing=8(0.10) | |
|
| The Netherlands | 3715 (92.99) | 3777 (92.87) | 7492 (92.93) |
|
| Other | 276 (6.91) | 286 (7.03) | 562 (6.97) |
|
| Nmissing=7 (0.18) | Nmissing=6 (0.15) | Nmissing=13 (0.16) | |
|
| Protestant | 753 (18.85) | 737 (18.12) | 1490 (18.48) |
|
| Not protestant | 3235 (80.98) | 3324 (81.73) | 6559 (81.36) |
|
| Nmissing=4 (0.10) | Nmissing=3 (0.07) | Nmissing=7 (0.09) | |
|
| Low | 588 (14.72) | 540 (12.28) | 1128 (13.99) |
|
| Middle | 1736 (43.45) | 1735 (42.66) | 3471 (43.05) |
|
| High | 1660 (41.55) | 1786 (43.91) | 3446 (42.74) |
| HPVa vaccination uptake, n (%) | 2923 (73.17) | 2957 (72.71) | 5880 (72.93) | |
aHPV: human papillomavirus.
Effects of the intervention on the outcome measures according to intention-to-treat analyses (N=8062).
| Outcome | Control (N=4067) | Intervention (N=3995) | Beta | Cohen ƒ2 or OR | ||||||||||
| Pretest | Posttest | Pretest | Posttest | |||||||||||
| Primary outcome |
|
|
|
|
|
| ||||||||
|
|
|
|
|
|
|
|
| |||||||
|
|
| Has received no HPV injection (reference), n (%) |
| 1106 (27.19) |
| 1066 (26.67) |
|
| ||||||
|
|
| Has received one or two HPV injections, n (%) |
| 2961 (72.81) |
| 2929 (73.32) | .03 (.05)b | 1.03 | ||||||
| Secondary outcomes |
|
|
|
|
|
| ||||||||
|
|
|
|
|
|
|
|
| |||||||
|
|
| Not informed (reference), n (%) | 2689 (66.12) | 1924 (47.31) | 2689 (67.31) | 1699 (42.53) |
|
| ||||||
|
|
| Informed, n (%) | 1376 (33.83) | 2143 (52.69) | 1306 (32.69) | 2296 (57.47) | .25 (.06)c | 1.28 | ||||||
|
| IDM: continuous (0-48), mean (SD) | 18.95 (11.45) | 24.28 (11.82) | 18.69 (11.21) | 25.85 (12.30) | 1.72 (.27)c | 0.007 | |||||||
|
| Decisional conflict (1-7), mean (SD) | 4.33 (1.74) | 5.17 (1.45) | 4.33 (1.75) | 5.38 (1.36) | .21 (.04)c | 0.008 | |||||||
|
| Intention (1-7), mean (SD) | 5.35 (1.70) | 5.42 (1.97) | 5.35 (1.69) | 5.59 (1.87) | .18 (.03)c | 0.006 | |||||||
|
| Attitude (1-7), mean (SD) | 5.19 (1.46) | 5.22 (1.57) | 5.18 (1.45) | 5.37 (1.51) | .15 (.03)c | 0.006 | |||||||
|
| Beliefs (1-7), mean (SD) | 4.21 (.72) | 4.37 (.80) | 4.19 (.73) | 4.47 (.81) | .12 (.02)c | 0.010 | |||||||
|
| Risk perception not vaccinated (1-7), mean (SD) | 3.73 (.98) | 3.70 (1.05) | 3.74 (0.98) | 3.77 (1.08) | .06 (.02)d | 0.001 | |||||||
|
| Risk perception vaccinated (1-7), mean (SD) | 2.76 (1.06) | 2.74 (1.08) | 2.77 (1.07) | 2.64 (1.10) | −.11 (.03)c | 0.004 | |||||||
|
| Anticipated regret (1-5), mean (SD) | 3.68 (1.27) | 3.50 (1.33) | 3.71 (1.25) | 3.59 (1.31) | .07 (.03)d | 0.001 | |||||||
|
| Subjective norm (−20 to 20), mean (SD) | 5.92 (7.90) | 6.46 (9.46) | 5.88 (7.81) | 7.25 (9.20) | .82 (.20)c | 0.004 | |||||||
|
| Habit (1-7), mean (SD) | 4.26 (1.79) | 4.36 (1.82) | 4.28 (1.78) | 4.51 (1.83) | .14 (.04)c | 0.004 | |||||||
|
| Relative effectiveness (1-10), mean (SD) | −2.01 (2.24) | −1.84 (2.36) | −1.97 (2.22) | −1.35 (2.27) | .46 (.07)c | 0.015 | |||||||
|
| Self-efficacy (1-7), mean (SD) | 6.24 (.76) | 6.24 (.78) | 6.27 (.73) | 6.29 (.75) | .04 (.02)e | 0.001 | |||||||
|
| Knowledge (−8 to 8), mean (SD) | 4.42 (2.16) | 5.41 (2.09) | 4.40 (2.14) | 5.75 (2.09) | .35 (.05)c | 0.009 | |||||||
aHuman papillomavirus (HPV) vaccination uptake was not assessed at baseline.
bP=.60.
cP ≤.001, thus significant (P<.003; Bonferroni: 0.05/14 factors).
dP=.01.
eP=.03.
Moderation effects of intention subgroups on the outcome measures according to the intention-to-treat analyses (N=8062).
| Outcome | Negative—in doubt | Negative—positive | In doubt—positive | |||||||
|
| Beta | Beta | Beta | |||||||
| Primary outcome |
|
|
|
|
|
| ||||
|
|
|
|
|
|
|
|
| |||
|
|
| Has received no HPV injection (reference) |
|
|
|
|
|
| ||
|
|
| Has received one or two HPV injections | −.21 (.13) | .22 | .01 (.18) | .97 | .22 (.18) | .24 | ||
| Secondary outcomes |
|
|
|
|
|
| ||||
|
|
|
|
|
|
|
|
| |||
|
|
| Not informed (reference) |
|
|
|
|
|
| ||
|
|
| Informed | .18 (.15) | .22 | .09 (.15) | .56 | −.10 (.14) | .50 | ||
|
| IDM: continuous (0-48) | .92 (.69) | .18 | 1.03 (.65) | .12 | .11 (.65) | .87 | |||
|
| Decisional conflict (1-7) | .26 (.08) | .001c | .04 (.07) | .57 | .22 (.08) | .004 | |||
|
| Intention (1-7) | −.26 (.08) | .002c | −.40 (.08) | <.001c | −.14 (.07) | .03 | |||
|
| Attitude (1-7) | −.17 (.06) | .009 | −.21 (.06) | .001c | −.04 (.06) | .51 | |||
|
| Beliefs (1-7) | −.04 (.04) | .36 | −.02 (.04) | .68 | .02 (.04) | .67 | |||
|
| Risk perception not vaccinated (1-7) | .04 (.07) | .51 | .09 (.07) | .18 | .05 (.06) | .41 | |||
|
| Risk perception vaccinated (1-7) | .04 (.06) | .51 | −.06 (.07) | .38 | −.10 (.07) | .17 | |||
|
| Anticipated regret (1-5) | −.03 (.07) | .70 | .02 (.07) | .81 | .04 (.06) | .46 | |||
|
| Subjective norm (−10 to 10) | −1.18 (.47) | .01 | −1.64 (.43) | <.001c | −.46 (.37) | .22 | |||
|
| Habit (1-7) | .08 (.08) | .34 | .06 (.08) | .45 | −.01 (.07) | .87 | |||
|
| Relative effectiveness (1-10) | −.39 (.12) | .001c | −.53 (.12) | <.001c | −.14 (.11) | .21 | |||
|
| Self-efficacy (1-7) | −.00 (.05) | .97 | .03 (.04) | .45 | .03 (.05) | .50 | |||
|
| Knowledge (−8 to 8) | −.01 (.13) | .92 | −.13 (.12) | .29 | −.11 (.12) | .34 | |||
aHPV: human papillomavirus.
bIDM: informed decision making.
cP<.003, thus significant (Bonferroni: 0.05/14 factors).